Rolfes, M.; Borde, J.; Möllenhoff, K.; Kayali, M.; Ernst, C.; Gehrig, A.; Sutter, C.; Ramser, J.; Niederacher, D.; Horváth, J.;
et al. Prevalence of Cancer Predisposition Germline Variants in Male Breast Cancer Patients: Results of the German Consortium for Hereditary Breast and Ovarian Cancer. Cancers 2022, 14, 3292.
https://doi.org/10.3390/cancers14133292
AMA Style
Rolfes M, Borde J, Möllenhoff K, Kayali M, Ernst C, Gehrig A, Sutter C, Ramser J, Niederacher D, Horváth J,
et al. Prevalence of Cancer Predisposition Germline Variants in Male Breast Cancer Patients: Results of the German Consortium for Hereditary Breast and Ovarian Cancer. Cancers. 2022; 14(13):3292.
https://doi.org/10.3390/cancers14133292
Chicago/Turabian Style
Rolfes, Muriel, Julika Borde, Kathrin Möllenhoff, Mohamad Kayali, Corinna Ernst, Andrea Gehrig, Christian Sutter, Juliane Ramser, Dieter Niederacher, Judit Horváth,
and et al. 2022. "Prevalence of Cancer Predisposition Germline Variants in Male Breast Cancer Patients: Results of the German Consortium for Hereditary Breast and Ovarian Cancer" Cancers 14, no. 13: 3292.
https://doi.org/10.3390/cancers14133292
APA Style
Rolfes, M., Borde, J., Möllenhoff, K., Kayali, M., Ernst, C., Gehrig, A., Sutter, C., Ramser, J., Niederacher, D., Horváth, J., Arnold, N., Meindl, A., Auber, B., Rump, A., Wang-Gohrke, S., Ritter, J., Hentschel, J., Thiele, H., Altmüller, J.,
... Hauke, J.
(2022). Prevalence of Cancer Predisposition Germline Variants in Male Breast Cancer Patients: Results of the German Consortium for Hereditary Breast and Ovarian Cancer. Cancers, 14(13), 3292.
https://doi.org/10.3390/cancers14133292